LLY · Company research
Eli Lilly & Co. (LLY): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 1157.49 | $1,058,960,008,000 | 1050010008000.00 | 39.672719948977885 | — | 1.5123721726004296 | 46.0938455645512318 | 31.2571211665043242 | 136.5166956297537714 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.